UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome‐positive acute lymphoblastic leukemia

Cancer science, 2019-10, Vol.110 (10), p.3255-3266

2019

Link zum Volltext

Verfügbarkeit prüfen

Human Herpesvirus 6 (HHV-6) Reactivation and HHV-6 Encephalitis After Allogeneic Hematopoietic Cell Transplantation: A Multicenter, Prospective Study

Clinical infectious diseases, 2013-09, Vol.57 (5), p.671-681

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm

Blood, 2015-06, Vol.125 (23), p.3559-3562

2015

Link zum Volltext

Verfügbarkeit prüfen

Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis

Bone marrow transplantation (Basingstoke), 2022-01, Vol.57 (1), p.78-82

2022

Link zum Volltext

Verfügbarkeit prüfen

Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT

Bone marrow transplantation (Basingstoke), 2020-07, Vol.55 (7), p.1317-1325

2020

Link zum Volltext

Verfügbarkeit prüfen

Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis

Bone marrow transplantation (Basingstoke), 2021-12, Vol.56 (12), p.3008-3015

2021

Link zum Volltext

Verfügbarkeit prüfen

Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia

Annals of hematology, 2022-03, Vol.101 (3), p.643-653

2022

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic or pre-emptive therapies to prevent relapse after allogeneic hematopoietic stem cell transplantation

International journal of hematology, 2023-08, Vol.118 (2), p.155-157

Kako, Shinichi

2023

Link zum Volltext

Verfügbarkeit prüfen

Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type

Clinical cancer research, 2021-09, Vol.27 (17), p.4825-4835

2021

Link zum Volltext

Verfügbarkeit prüfen

Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia

International journal of hematology, 2021-06, Vol.113 (6), p.832-839

2021

Link zum Volltext

Verfügbarkeit prüfen

Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine

Cancer science, 2021-12, Vol.112 (12), p.5034-5045

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of graft‐versus‐host disease and graft‐versus‐leukemia effect based on minimal residual disease in Philadelphia chromosome‐positive acute lymphoblastic leukemia

British journal of haematology, 2020-07, Vol.190 (1), p.84-92

2020

Link zum Volltext

Verfügbarkeit prüfen

Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT

International journal of hematology, 2022-05, Vol.115 (5), p.748-752

2022

Link zum Volltext

Verfügbarkeit prüfen

Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors

International journal of hematology, 2021-12, Vol.114 (6), p.674-681

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation

International journal of hematology, 2022-08, Vol.116 (2), p.239-247

2022

Link zum Volltext

Verfügbarkeit prüfen

Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL

Leukemia, 2022-05, Vol.36 (5), p.1361-1370

2022

Link zum Volltext

Verfügbarkeit prüfen

Persistent Expression of Recipient-type ABH Antigen after ABO-incompatible Allogeneic Hematopoietic Stem Cell Transplantation

Internal Medicine, 2022/06/15, Vol.61(12), pp.1887-1890

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission

Bone marrow transplantation (Basingstoke), 2021-11, Vol.56 (11), p.2779-2787

2021

Link zum Volltext

Verfügbarkeit prüfen

The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia

Annals of hematology, 2021-12, Vol.100 (12), p.3017-3027

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of chromosomal changes at relapse after allogeneic hematopoietic cell transplantation for acute myeloid leukemia or myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2022-05, Vol.57 (5), p.810-816

2022

Link zum Volltext

Verfügbarkeit prüfen

Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy

International journal of hematology, 2021-11, Vol.114 (5), p.608-619

2021

Link zum Volltext

Verfügbarkeit prüfen

Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL

Leukemia, 2022-05, Vol.36 (5), p.1361-1370

2022

Link zum Volltext

Verfügbarkeit prüfen

Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents

Bone marrow transplantation (Basingstoke), 2022-05, Vol.57 (5), p.846-848

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 296

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(249)
Mit Volltextzugriff
(276)

Publikationsform

Sprache

Englisch
(288)
Japanisch
(97)

Erscheinungsjahr

n.n

Thema

Science & Technology
(215)
Life Sciences & Biomedicine
(205)
Hematology
(163)
Humans
(144)
Transplantation
(101)
Adult
(89)
Female
(88)
Oncology
(88)
Male
(86)
Middle Aged
(82)
Retrospective Studies
(73)
Immunology
(70)
Stem Cell Transplantation
(69)
Hematopoietic Stem Cell Transplantation
(61)
Adolescent
(57)
Hematopoietic Stem Cells
(51)
Aged
(49)
Medicine
(43)
Medicine & Public Health
(43)
Young Adult
(43)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome‐positive acute lymphoblastic leukemia

Human Herpesvirus 6 (HHV-6) Reactivation and HHV-6 Encephalitis After Allogeneic Hematopoietic Cell Transplantation: A Multicenter, Prospective Study

Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm

Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis

Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT

Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis

Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia

Prophylactic or pre-emptive therapies to prevent relapse after allogeneic hematopoietic stem cell transplantation

Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study

Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type

Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia

Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine

Impact of graft‐versus‐host disease and graft‐versus‐leukemia effect based on minimal residual disease in Philadelphia chromosome‐positive acute lymphoblastic leukemia

Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT

Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors

Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation

Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL

Persistent Expression of Recipient-type ABH Antigen after ABO-incompatible Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission

The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia

Prognostic impact of chromosomal changes at relapse after allogeneic hematopoietic cell transplantation for acute myeloid leukemia or myelodysplastic syndrome

Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy

Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL

Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents

Suchergebnisse filtern